108 related articles for article (PubMed ID: 32633346)
1. Expression level of miRNA-210-3p in cervical cancer and its prognostic potential.
Shao MX; Qu AZ; Wang YQ; Zhong YY
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6583-6588. PubMed ID: 32633346
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA Biomarkers of High-Grade Cervical Intraepithelial Neoplasia in Liquid Biopsy.
Causin RL; da Silva LS; Evangelista AF; Leal LF; Souza KCB; Pessôa-Pereira D; Matsushita GM; Reis RM; Fregnani JHTG; Marques MMC
Biomed Res Int; 2021; 2021():6650966. PubMed ID: 33954190
[TBL] [Abstract][Full Text] [Related]
3. Identification of miRNAs in cervical mucus as a novel diagnostic marker for cervical neoplasia.
Kawai S; Fujii T; Kukimoto I; Yamada H; Yamamoto N; Kuroda M; Otani S; Ichikawa R; Nishio E; Torii Y; Iwata A
Sci Rep; 2018 May; 8(1):7070. PubMed ID: 29728572
[TBL] [Abstract][Full Text] [Related]
4. A Novel Circulating MiRNA-Based Signature for the Diagnosis and Prognosis Prediction of Early-Stage Cervical Cancer.
Qiu H; Liang D; Liu L; Xiang Q; Yi Z; Ji Y
Technol Cancer Res Treat; 2020; 19():1533033820970667. PubMed ID: 33327867
[TBL] [Abstract][Full Text] [Related]
5. Promoter Methylation of Ezrin and its Impact on the Incidence and Prognosis of Cervical Cancer.
Qin R; Cao L; Wang J; Liu J
Cell Physiol Biochem; 2018; 50(1):277-287. PubMed ID: 30282070
[TBL] [Abstract][Full Text] [Related]
6. Dysregulation of miRNA-21 and their potential as biomarkers for the diagnosis of cervical cancer.
Han Y; Xu GX; Lu H; Yu DH; Ren Y; Wang L; Huang XH; Hou WJ; Wei ZH; Chen YP; Cao YG; Zhang R
Int J Clin Exp Pathol; 2015; 8(6):7131-9. PubMed ID: 26261606
[TBL] [Abstract][Full Text] [Related]
7. Expression of microRNA-142-3p in cervical cancer and its correlation with prognosis.
Li M; Li BY; Xia H; Jiang LL
Eur Rev Med Pharmacol Sci; 2017 May; 21(10):2346-2350. PubMed ID: 28617557
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA expression profiling and Notch1 and Notch2 expression in minimal deviation adenocarcinoma of uterine cervix.
Lee H; Kim KR; Cho NH; Hong SR; Jeong H; Kwon SY; Park KH; An HJ; Kim TH; Kim I; Yoon HK; Suh KS; Min KO; Choi HJ; Park JY; Yoo CW; Lee YS; Lee HJ; Lee WS; Park CS; Lee Y;
World J Surg Oncol; 2014 Nov; 12():334. PubMed ID: 25381598
[TBL] [Abstract][Full Text] [Related]
9. Circulating and tissue miR-100 acts as a potential diagnostic biomarker for cervical cancer.
Yamanaka Z; Sasaki T; Yamanaka A; Kato K; Nishi H
Cancer Biomark; 2021; 32(4):551-558. PubMed ID: 34334379
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of miR-329-3p is associated with worse prognosis in patients with cervical cancer.
Chang YH; Yin F; Fan GF; Zhao M
Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4045-4049. PubMed ID: 29028098
[TBL] [Abstract][Full Text] [Related]
11. Association study of relationships of polymorphisms in the miR-21, miR-26b, miR-221/222 and miR-126 genes with cervical intraepithelial neoplasia and cervical cancer.
Yang J; Yan Z; Wang Y; Xu J; Li R; Li C; Liu S; Shi L; Yao Y
BMC Cancer; 2021 Sep; 21(1):997. PubMed ID: 34488676
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-378a-3p Downregulation as a Novel Biomarker with Poor Clinical Outcomes in Cervical Cancer.
Zhang L; Wu ZA
Biomed Environ Sci; 2021 Mar; 34(3):213-221. PubMed ID: 33766217
[TBL] [Abstract][Full Text] [Related]
13. Octamer binding transcription factor-4 expression is associated with cervical cancer malignancy and histological differentiation: a systematic review and meta-analysis.
Gao ZY; Liu XB; Yang FM; Liu L; Zhao JZ; Gao B; Li SB
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30979828
[No Abstract] [Full Text] [Related]
14. Reduced expression of miR-503 is associated with poor prognosis in cervical cancer.
Yin ZL; Wang YL; Ge SF; Guo TT; Wang L; Zheng XM; Liu J
Eur Rev Med Pharmacol Sci; 2015 Nov; 19(21):4081-5. PubMed ID: 26592830
[TBL] [Abstract][Full Text] [Related]
15. microRNA-944 overexpression is a biomarker for poor prognosis of advanced cervical cancer.
Park S; Kim J; Eom K; Oh S; Kim S; Kim G; Ahn S; Park KH; Chung D; Lee H
BMC Cancer; 2019 May; 19(1):419. PubMed ID: 31060525
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA expression in cervical cancer: Novel diagnostic and prognostic biomarkers.
Gao C; Zhou C; Zhuang J; Liu L; Liu C; Li H; Liu G; Wei J; Sun C
J Cell Biochem; 2018 Aug; 119(8):7080-7090. PubMed ID: 29737570
[TBL] [Abstract][Full Text] [Related]
17. Expression of GMFB in High-Grade Cervical Intraepithelial Neoplasia and Its Role in Cervical Cancer.
Tian J; Wang J; Chi Y; Han Z; Zhang D; Zhang H
Comput Math Methods Med; 2022; 2022():7784921. PubMed ID: 36238479
[TBL] [Abstract][Full Text] [Related]
18. Exosomal let-7d-3p and miR-30d-5p as diagnostic biomarkers for non-invasive screening of cervical cancer and its precursors.
Zheng M; Hou L; Ma Y; Zhou L; Wang F; Cheng B; Wang W; Lu B; Liu P; Lu W; Lu Y
Mol Cancer; 2019 Apr; 18(1):76. PubMed ID: 30940131
[TBL] [Abstract][Full Text] [Related]
19. A microRNA-Messenger RNA Regulatory Network and Its Prognostic Value in Cervical Cancer.
Liu J; Yang J; Gao F; Li S; Nie S; Meng H; Sun R; Wan Y; Jiang Y; Ma X; Cheng W
DNA Cell Biol; 2020 Jul; 39(7):1328-1346. PubMed ID: 32456463
[TBL] [Abstract][Full Text] [Related]
20. Dysregulated microRNA expression in adenocarcinoma of the uterine cervix: clinical impact of miR-363-3p.
Park H; Lee MJ; Jeong JY; Choi MC; Jung SG; Joo WD; Lee C; An HJ
Gynecol Oncol; 2014 Dec; 135(3):565-72. PubMed ID: 25230213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]